LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), an institutional commodity tokenization company, today announced that it has received formal approval from Nasdaq for continued listing of its shares of common stock on the Nasdaq Capital Market under the ticker symbol “STEX.” In conjunction with the Nasdaq approval, Streamex will convene a special meeting of shareholders at 3:00 PM EST on November 4, 2025, to reconvene the previously adjourned Propos ...

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced two poster presentations featuring BBO-10203, a first-in-class, orally bioavailable, selective breaker of the RAS:PI3Kα interaction, at the San Antonio Breast Cancer Symposium (SABCS) being held December 9-12, 2025, in San Antonio, Texas. The abstracts released today can be found on the SA ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter ended September 30, 2025. Business Update Discretionary assets under management (“AUM”), which primarily drives the firm’s top-line revenue, increased $687 million during the third quarter, primarily due to beneficial equity markets. Silvercrest added $46.4 million in organic new client accounts during the third quart ...

DALLAS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated October 29, 2025, the Company was notified by The Nasdaq Stock Market, LLC (“Nasdaq”) that the Company had regained compliance with (i) the Nasdaq periodic reporting requiremen ...

Gran Tierra Secures $200 Million Prepayment Facility Highlighting Strength of Portfolio Increase and Extension of Canadian Credit Facility Three Major Ecuador Discoveries Add to the Existing Success in Country Colombia’s Southern Putumayo Cohembi Field Achieves Highest Production in a Decade CALGARY, Alberta, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE: GTE) announced the Company’s financial and operating results for the quart ...

MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. JORNAY PM™ is an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children 6-12 years of age.1 “Effective ADHD management begins with helping children transition smoot ...

财务业绩概览 - 2025财年第一季度净销售额为4,070,778美元，较上年同期的3,201,868美元增长868,910美元，增幅达27.1% [2] - 季度净收入为243,729美元，相比上年同期净亏损419,535美元，实现扭亏为盈 [2] - 基本和稀释后每股收益均为0.03美元，上年同期为每股亏损0.05美元 [2] 销售表现驱动因素 - 销售额增长主要得益于向最大教育市场客户的一笔可观销售，以及直接面向消费者（DTC）业务22.5%的销售增长 [3] - 尽管欧洲销售额因两大分销商将补货订单推迟至下季度而同比下降，但亚洲市场的强劲销售弥补了部分出口缺口 [3] - DTC销售增长得益于新产品发布以及上一财年推出的产品新配色 [3] 盈利能力与成本分析 - 毛利率从去年同期的36.6%提升至40.0%，改善了340个基点，主要原因是客户和市场组合优化，特别是高利润率DTC销售额占比提升 [3] - 销售、一般及行政费用从上年同期的1,810,059美元降至1,674,732美元 [9] - 运营亏损从上年同期的637,133美元大幅收窄至46,040美元 [9] 其他收入与运营亮点 - 其他净收入为292,529美元，主要来自293,128美元的利息收入 [9] - 公司产品组合包括高保真耳机、无线蓝牙扬声器、电脑耳麦、通信耳麦、主动降噪耳机和无线耳机 [6] 管理层变动与战略 - Michael J Koss, Jr 晋升为执行副总裁，以表彰其在新产品创造、DTC业务增长以及公司专利知识产权相关执法行动中的领导作用 [5] - 该高管将继续负责市场营销和产品工作，并新增对采购和物流团队的监督职责 [5]

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025 Mont-Saint-Guibert, Belgium – Thursday, October 30, 2025, 10:10pm CET / 5:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the second quarter of 2025 on Thursday, November 13, 2025. Company management will host a conference ca ...

TORONTO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. ("Matador" or the "Company") (TSXV: MATA, OTCQB: MATAF, FSE: IU3), the Bitcoin Ecosystem Company, announces that it has entered into a consulting agreement with Team Dyno Limited ("Dyno") dated effective October 29, 2025 (the "Agreement"), to provide investor relations services to the Company. Dyno will assist the Company in investor relations and business development strategy. The agreement is for a term of six (6) months, commencing on O ...

Completion of Private Placement of New Shares as Part of Series A Round Valued at ¥9 BillionTOKYO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Co., Ltd. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter “MEDIROM MOTHER Labs”), a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), has completed a private placement of new shares to its President and CEO, Yoshio Uekusa, and Director, Ryo Saito. This transaction is part of the previously announced Series A ro ...